MUC5B and pulmonary fibrosis: MUC5B rs35705950 in one report was found to be protective in terms of COVID-19 hospitalization [32], but not severity, and it was associated with less severe disease according to another publication [33], although carriers of the minor variant are known to be more susceptible to idiopathic pulmonary fibrosis [49].